Articles On Rhinomed (ASX:RNO)

Each week, Stockhead recaps ASX stocks that are “running hot” as deduced by the Relative Strength Index (RSI). The RSI is a technical gauge which measures how trading momentum is affecting the price action. A reading of 70 is seen as the le...

This week Technicorum Holdings announced an upcoming token sale and launch of The CanCoin – a cannabis token designed to solve market friction and monetisation in the European cannabis market and to help build blockchain-based solutions for...

The ASX 200 index closed near its lows Thursday, falling by 0.39% on lower-than-normal volume. Nine out of 11 sectors were lower, led by Health Care, which lost 1.44%. The Materials sector – which includes chemicals and plastics, constructi...

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

It’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52 losing it – and 21 flatlining. Botanix Pharma Ltd (ASX:BOT) was the biggest gainer, up 38% from 23 June to 7 July, and Suda Pharmaceuticals...

The US cannabis sector received a big lift after Amazon announced that job applicants at its offices and warehouses will no longer be drug-tested for marijuana use. Delivery drivers, however, will still be tested. The company also said it w...

Here’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has returned 2.3 per cent for the last two weeks, compared to the broader market which rose by 2.7 per cent. The biggest news globally was out of U...

There was plenty of action in the US regulatory front within the cannabis sector this week. A couple of major legislations during the week could potentially shake up the US cannabis industry. The Marijuana Opportunity Reinvestment and Expun...

In 2021, which of Europe and North America is the place to be for ASX cannabis stocks?   The case for Europe A few years ago there would’ve been no question that it was North America with Canada legalising recreational cannabis as well as h...

Closing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intraday trade. WINNERS Scrol...

The wearable nasal and respiratory technology maker, Rhinomed (ASX:RNO), has been on a roll lately, with its share price surging since the announcement of its solid quarter on 30 April. Prior to today’s correction of around 8 per cent, the...

A cannabis-based drug has been listed on Australia’s Pharmaceutical Benefits Scheme for the first time, as medical marijuana gains increased acceptance. The move means that an estimated 116 Aussies with a rare form of epilepsy known as Drav...

Closing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intraday trade. WINNERS Scr...

April 20 has come and gone, but ASX cannabis companies aren’t getting that high — they’re actually low. Of the 36 pot companies in the space, 27 have lost ground over the last fortnight. Just seven have advanced. Gains were led by Wide Open...

The number of medical cannabis prescriptions issued under Australia’s special access scheme just keeps on growing. There were a record 9,959 SAS Category B marijuana prescriptions issued in March, two and a half times the number from a year...

Australia’s medical marijuana industry is showing strong growth, according to an industry-leading biannual report. The Freshleaf Analytics report, released this morning, says that patient numbers have grown 15-fold over the past two and a h...

Here’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks for small-cap health companies, with 58 companies gaining ground and 54 losing it. Another 16 were flat. Code Company Price % return...

Pot legalisation is creeping across the US state by state, and a major market could be about to join their ranks. Reports out of New York indicate that lawmakers in the Empire State are close to signing a new bill legalising recreational ca...

Source: photastic ,Shutterstock Summary Brookside Energy is trading 25 per cent up at A$0.02. Metalicity is maintaining its three days winning streak and is up by 21.3 per cent today. Janison Education’s share has given a strong brea...

Australian respiratory company Rhinomed (ASX:RNO) has reported positive data from its lab-based spiking study of its new Rhinoswab conducted at the Victorian Infectious Diseases Reference Laboratory.

Nasal airway and respiratory technology company Rhinomed (ASX:RNO) has announced the TGA has registered its high load capturing nasal swab as a Class 1 device.

Australian respiratory company Rhinomed (ASX:RNO) says it is advanced in developing a new high-yielding nasal swab that can collect samples from the nose to test for the presence of upper respiratory tract diseases, including influe...

A quick wrap of the ASX’s key winners and losers on Wednesday, September 16. Data is taken after the market closes at 4pm AEST. Stocks highlighted in yellow made potentially market-moving announcements during the day. WINNERS TICKE...

A quick wrap of the ASX’s key winners and losers on Tuesday, September 15. Data is taken after the market closes at 4pm AEST. Stocks highlighted in yellow made potentially market-moving announcements during the day. WINNERS TICKER N...

The Rhinomed Ltd (ASX: RNO) share price surged to a six-month high as it takes a leaf out of the Starpharma Holdings Limited (ASX: SPL) playbook. The Rhinomed share price rallied 84% ahead of the market close to $0.14 after management said...

Rhinomed (ASX:RNO) shares have soared over 90 per cent to a six-month high after the airway technology company said it had created a less invasive nasal swab that could be self-administered to test for flu and “coronavirus strains”. Rhinome...

Australian nasal airway and respiratory technology specialist Rhinomed (ASX: RNO) has announced it is developing a new-generation nasal swab capable of collecting samples to test for the presence of upper respiratory tract diseases, includi...

ASX cannabis stocks are continuing their victory lap following yesterday’s decision by the TGA to re-classify low-dose cannabidiol (CBD) products. The TGA has made an interim decision to down schedule CBD products, including oil and pills,...

It was a little from Column A and a little from Column B for local cannabis stocks this week, as investors look for breakthroughs in the sector amid the broader market rally. Of the 34 cannabis (or cannabis-adjacent) small caps tracked by S...

Would you have invested in Amazon in the 90s, when it was a scrappy startup exploiting this new thing called the ‘world wide web’? Or would you invest once it had bedded down the book business and was getting into groceries? With hindsight...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

The Australian sharemarket officially entered a bear market yesterday — defined as a cumulative fall of more than 20 per cent. Aside from some gold miners, almost no sector has been spared from the virus-related carnage. And cannabis stocks...

For an industry that’s projected to reach $US20 billion ($29 billion) by 2024 in the US, the cannabidiol (CBD) market there is very much the wild west. A study from researcher Leafreport comparing 3500 products for the sale in the US from 5...

Air pollution is a growing problem that in recent days has reached our own backyard. Because of the bushfires in surrounding areas, Sydney’s air has been ranked the ninth worst in the world. It’s not the first time in history it’s happened...

Cannabis Shares Valuing a cannabis company is becoming an increasingly difficult task. Lately, the cannabis shares have been taking a beat in the domestic markets, falling from their respective all-time highs. The table below provides you w...

It’s been another interesting week in the realm of Australian cannabis regulation. For starters, the ACT legislature’s recent decision to legalise marijuana possession (up to a maximum of 50 grams) continued to grab some headlines. Senior m...

Kicking back at your favourite cafe and smoking a joint is an activity historically associated with pot-friendly cities such as Amsterdam. But as of this week, that right has now been extended to US citizens with the grand opening of Americ...

It was in July that Finfeed last caught up with Rhinomed Ltd (ASX:RNO), highlighting the success of its Mute nasal stent, the fastest growing product in the nasal strip category in US based drug stores. The DrugStores News Management’s Annu...

All eyes were on the nation’s capital yesterday, as the ACT became the first Australian state or territory to legalise marijuana possession. The new laws are expected to come into effect on January 31, 2020. The bill, proposed by Labor back...

Digital transformation is changing the lives of patients and the fortunes of med-tech companies. As we have seen with the likes of Alcidion (ASX:ALC) and Rhinomed (ASX:RNO) and BPH Energy (ASX:BPH), med tech development is crucial to the me...

On Stockhead today, why Australia’s telco sector is “mission critical, Amazon finds spare change under couch cushion and orders 100,000 EVs and WA mining smashes employment and sales records. But first:   The day ahead The Reserve Bank of A...

Medical tech company Rhinomed (ASX:RNO) has hit the ground running after coming out of a trading halt this morning. Shares in the company jumped around 40 per cent to 33.5c, after the successful completion of a $6m share placement. The fund...

Cancer-fighting biotech Immutep (ASX:IMM) has risen off 10-year-long lows after flagging a payment of $7.4m from British pharma giant GSK. Immutep shares got a 14 per cent boost to 2.5c, after closing at 2.2c on Friday. The share price has...

On Stockhead today, Benchmark’s Simon Moores on identifying the bulls*&t in battery metals analysis, the oil and gas players that are looking for the next big hit in the Perth Basin and sitting fireside with the “Wildcatter” is Helios E...

Breathing management med-tech business Rhinomed (ASX: RNO) has today listed in the USA on the OTCQB Venture Market. The company, which develops nasal and respiratory technologies to assist with sleep, sport and wellbeing, and is currently...

With growing focus of governments across the globe on legalising recreational and medicinal cannabis, the cannabis industry is booming at a rapid pace and is expected to offer opportunities for investors. In 2016, Australia became the fourt...

Penny Stocks Defined:   Penny stocks are the stocks belonging to small businesses and are usually priced below $ 5. The cap was earlier defined at $ 1 before the U.S Securities and Exchange Commission modified the definition to increase the...

Data analytics company Nielsen predicts that the American cannabis market will hit $US41 billion ($59.5 billion) by 2025 — a fivefold increase over 2018. While a good chunk of cannabis products are still illegal in the US, Nielsen reckons s...

Australia’s pharmaceutical industry is innovative and immensely supports economic prosperity of the nation. The constituent companies not only provide treatments to save lives but also contribute to Australian economy by undertaking busines...

The below-mentioned healthcare stocks have provided significant returns in the last six months and have come up with major updates today (i.e. 15th July 2019).  Let’s take a look at these updates. Rhinomed Limited (ASX: RNO) A Melbourne-ba...